The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $60.29

Today's change-0.53 -0.87%
Updated August 28 12:51 PM EDT. Delayed by at least 15 minutes.
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $60.29

Today's change-0.53 -0.87%
Updated August 28 12:51 PM EDT. Delayed by at least 15 minutes.

Bristol-Myers Squibb Co down (U.S.)$0.53

Bristol-Myers Squibb Co is lower today, dropping (U.S.)$0.53 or 0.87% to (U.S.)$60.29. Shares have lost 1.28% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 19.81% during the last year.

Key company metrics

  • Open(U.S.) $60.22
  • Previous close(U.S.) $60.82
  • High(U.S.) $61.05
  • Low(U.S.) $60.11
  • Bid / Ask(U.S.) $60.28 / (U.S.) $60.30
  • YTD % change+2.13%
  • Volume2,110,386
  • Average volume (10-day)7,904,087
  • Average volume (1-month)6,380,360
  • Average volume (3-month)6,639,215
  • 52-week range(U.S.) $47.55 to (U.S.) $70.54
  • Beta0.34
  • Trailing P/E56.39×
  • P/E 1 year forward33.18×
  • Forward PEG1.67×
  • Indicated annual dividend(U.S.) $1.48
  • Dividend yield2.45%
  • Trailing EPS(U.S.) $1.07
Updated August 28 12:51 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.50%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue4,1634,0414,2583,921
Total other revenue--------
Total revenue4,1634,0414,2583,921
Gross profit3,1753,2283,3232,950
Total cost of revenue988813935971
Total operating expense4,1182,7524,3183,210
Selling / general / administrative1,1351,0291,3641,200
Research & development9851,0161,139918
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1,14498927192
Other operating expenses, total-134-204-47-71
Operating income451,289-60711
Interest income (expense), net non-operating-49-51-53-50
Gain (loss) on sale of assets8154-3315
Other--------
Income before tax521,448-601,008
Income after tax-1101,19927732
Income tax, total162249-87276
Net income-1301,18613721
Total adjustments to net income--------
Net income before extra. items-1301,18613721
Minority interest-20-13-14-11
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1301,18613721
Inc. avail. to common incl. extra. items-1301,18613721
Diluted net income-1301,18613721
Dilution adjustment--------
Diluted weighted average shares1,6671,6761,6761,670
Diluted EPS excluding extraordinary itemsvalue per share-0.080.710.010.43
Dividends per sharevalue per share0.370.370.370.36
Diluted normalized EPSvalue per share0.430.660.380.35